New Zealand markets closed

Therapeutic Solutions International, Inc. (TSOI)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0009+0.0001 (+12.50%)
As of 01:53PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 3.38M
Enterprise value 4.24M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.61
Price/book (mrq)3.01
Enterprise value/revenue 42.87
Enterprise value/EBITDA -3.78

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-73.77%
S&P500 52-week change 322.26%
52-week high 30.0032
52-week low 30.0004
50-day moving average 30.0007
200-day moving average 30.0012

Share statistics

Avg vol (3-month) 329.5M
Avg vol (10-day) 316.14M
Shares outstanding 54.23B
Implied shares outstanding 64.23B
Float 83.25B
% held by insiders 121.54%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,336.14%

Management effectiveness

Return on assets (ttm)-36.00%
Return on equity (ttm)-166.83%

Income statement

Revenue (ttm)98.99k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)177.80%
Gross profit (ttm)N/A
EBITDA -1.67M
Net income avi to common (ttm)-2.17M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.82k
Total cash per share (mrq)0
Total debt (mrq)888.06k
Total debt/equity (mrq)69.28%
Current ratio (mrq)0.05
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.06M
Levered free cash flow (ttm)-218.15k